These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 18029909)
1. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909 [TBL] [Abstract][Full Text] [Related]
2. Antiatherosclerotic effect of farnesoid X receptor. Mencarelli A; Renga B; Distrutti E; Fiorucci S Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791 [TBL] [Abstract][Full Text] [Related]
3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753 [TBL] [Abstract][Full Text] [Related]
4. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431 [TBL] [Abstract][Full Text] [Related]
5. Expression and activation of the farnesoid X receptor in the vasculature. Bishop-Bailey D; Walsh DT; Warner TD Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3668-73. PubMed ID: 14990788 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064. Martínez-Fernández P; Hierro L; Jara P; Alvarez L Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886 [TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Wang YD; Chen WD; Wang M; Yu D; Forman BM; Huang W Hepatology; 2008 Nov; 48(5):1632-43. PubMed ID: 18972444 [TBL] [Abstract][Full Text] [Related]
8. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Swales KE; Korbonits M; Carpenter R; Walsh DT; Warner TD; Bishop-Bailey D Cancer Res; 2006 Oct; 66(20):10120-6. PubMed ID: 17047076 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430 [TBL] [Abstract][Full Text] [Related]
10. Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle. Kida T; Murata T; Hori M; Ozaki H Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H195-201. PubMed ID: 19011043 [TBL] [Abstract][Full Text] [Related]
11. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase. Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559 [TBL] [Abstract][Full Text] [Related]
12. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo. Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009 [TBL] [Abstract][Full Text] [Related]
14. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes. Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812 [TBL] [Abstract][Full Text] [Related]
15. Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets. Moraes LA; Unsworth AJ; Vaiyapuri S; Ali MS; Sasikumar P; Sage T; Flora GD; Bye AP; Kriek N; Dorchies E; Molendi-Coste O; Dombrowicz D; Staels B; Bishop-Bailey D; Gibbins JM Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2324-2333. PubMed ID: 27758768 [TBL] [Abstract][Full Text] [Related]
16. The bile acid receptor FXR is a modulator of intestinal innate immunity. Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602 [TBL] [Abstract][Full Text] [Related]
17. The farnesoid X receptor induces very low density lipoprotein receptor gene expression. Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Gineste R; Sirvent A; Paumelle R; Helleboid S; Aquilina A; Darteil R; Hum DW; Fruchart JC; Staels B Mol Endocrinol; 2008 Nov; 22(11):2433-47. PubMed ID: 18755856 [TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018 [TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β. Noh K; Kim YM; Kim YW; Kim SG Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]